AWE
EW icon

Avidian Wealth Enterprises’s Edwards Lifesciences EW Stock Holding History

Avidian Wealth Enterprises’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,007
Closed -$272K – 765
2026
Q2 		$272K Buy
+3,007
New +$252K 0.01% 623

Other funds holding EW

JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $514M AUM 11.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Avidian Wealth Enterprises's EW Position: Q3 2026 in Review

Avidian Wealth Enterprises sold out of Edwards Lifesciences (EW) in Q3 2026, closing a stake of 3,007 shares — an estimated $272K sold.

Avidian Wealth Enterprises first reported a position in EW in Q2 2026 and held it in 1 quarter. The position peaked at $272K in Q2 2026. 54 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Avidian Wealth Enterprises reported no remaining Edwards Lifesciences position as of Q3 2026 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 3,007 Edwards Lifesciences shares in Q3 2026, an estimated $272K.
  • Avidian Wealth Enterprises first reported a position in Edwards Lifesciences in Q2 2026 and held it in 1 quarter.
  • Avidian Wealth Enterprises's Edwards Lifesciences position peaked at $272K in Q2 2026.
  • 54 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.